Ligand Enters Into Captisol Commercial Supply Agreement With Merck

Ligand Pharmaceuticals Incorporated announced today that it has entered into a Captisol supply agreement with Merck & Co. for an undisclosed program. Ligand will supply clinical and commercial supplies of Captisol and, if the program is approved for commercialization, expects to deliver multiple metric tons of Captisol annually. Financial terms of the deal were not disclosed.
iStockAnalyst